Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. The company is valued at $162.7 billion by market cap. The leading global life sciences and diagnostics innovator is expected to announce its fiscal fourth-quarter earnings for 2025 before the market opens on Wednesday, Jan. 28. Ahead of the event, analysts expect DHR to report a profit of$2.14 per share on a diluted basis, unchang ...